Hikma Pharmaceuticals Public annual dividends paid
2020
2021
2022
2023
2024
2025
Hikma Pharmaceuticals Public Dividends Paid Growth & History (HIK)
Hikma Pharmaceuticals Public paid $185.0M in dividends during fiscal 2025.
View full Hikma Pharmaceuticals Public company overviewHikma Pharmaceuticals Public annual dividends paid history
| Fiscal year | Period ended | Dividends paid | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $185.0M | $10.0M | +5.71% |
| 2024 | 2024-12-31 | $175.0M | $38.0M | +27.74% |
| 2023 | 2023-12-31 | $137.0M | $12.0M | +9.60% |
| 2022 | 2022-12-31 | $125.0M | $5.0M | +4.17% |
| 2021 | 2021-12-31 | $120.0M | $11.0M | +10.09% |
| 2020 | 2020-12-31 | $109.0M | — | — |
Hikma Pharmaceuticals Public dividends paid trends
Over the last five fiscal years, Hikma Pharmaceuticals Public's dividends paid increased from $109.0M to $185.0M, a change of $76.0M.
About the metric
What dividends paid mean
Dividends paid are cash distributions made to shareholders. The history shows the company’s aggregate cash outflow for dividends, not the dividend per share, dividend yield, or the date an investor receives a payment.
Calculation and source
Reported cash dividends paid
TickerStat standardizes cash dividends paid to common or ordinary shareholders from official cash-flow filings. Reported zero-dividend periods remain zero and are not treated as missing data. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Hikma Pharmaceuticals Public source filings ↗Community posts
Hikma’s epinephrine nasal spray advances into regulatory review
Hikma ($HIK) said regulators in the United States, Europe and the UK have accepted submissions for its investigational epinephrine nasal spray for review. The company has also filed in Canada and intends to expand submissions to additional ...